News

May 100 min read

The Watchlist: Biosenta Inc. announces licensing agreement

Biosenta Inc. announces licensing agreement

31 views

May 83 min read

Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions

Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta’s Tri-Filler® technology and get fee of C$200,000 and royalties

65 views

Aug 11, 20231 min read

Solution fighting a drug-resistant fungus in hospitals of U.S. and Canada

UoC professor taking about a solution fighting a drug-resistant fungus that has become a big issue for hospitals in the U.S. and Canada.

21 views

Aug 8, 20235 min read

Biosenta announces further advances in research and development of Tri-Filler™

Biosenta Inc. announces further advances in research and development of the Tri-Filler™ particle.

96 views

Jun 23, 20237 min read

Biosenta announces entering into of agreement to terminate joint venture

52 views

May 31, 20231 min read

Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.

Biosenta Inc. announces that it has ceased negotiations with Voran Group Ventures Ltd.

46 views

Oct 26, 20221 min read

Summit-bound CEO sees promising future for Edmonton region

Chelsey Reschke is one of 47 Canadians attending the G20 Young Entrepreneurs’ Alliance summit in Hamburg from Oct. 27 to 28.

80 views

Oct 17, 20223 min read

Biosenta Inc. enters into an MOU with Voran Group Ventures Ltd.

Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.

74 views

May 26, 20223 min read

University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

46 views

Mar 28, 20225 min read

Biosenta Announces Shares for Debt Settlement

Biosenta Inc. announces that it has entered into an agreement to settle $1,015,088.47 of debt through issuance of 3,625,315 common shares.

78 views

Sep 9, 20202 min read

09/09/2020 - Biosenta Announces launching true™ in North America

Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America.

103 views